Qualitest announced that it has received approval from the FDA for its Abbreviated New Drug Application (ANDA) for Levetiracetam Extended-Release Tablets, the generic equivalent of UCB Pharma‘s Keppra XR

Keppra XR is indicated as an adjunct in partial onset seizures in patients ≥16yrs old.

Levetiracetam Extended-Release Tablets will be available from Qualitest in 500mg and 750mg dosage strengths.

For more information call (800) 462-ENDO or visit www.endo.com.